{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Marsdenia tenacissimae extraction", "PTEN", "T-cell acute lymphoblastic leukemia", "apoptosis", "proliferation"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27756877", "DateCompleted": {"Year": "2018", "Month": "02", "Day": "21"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [], "ELocationID": ["10.18632/oncotarget.12654"], "Language": ["eng"], "Journal": {"ISSN": "1949-2553", "JournalIssue": {"Volume": "7", "Issue": "50", "PubDate": {"Year": "2016", "Month": "Dec", "Day": "13"}}, "Title": "Oncotarget", "ISOAbbreviation": "Oncotarget"}, "ArticleTitle": "Marsdenia tenacissimae extraction (MTE) inhibits the proliferation and induces the apoptosis of human acute T cell leukemia cells through inactivating PI3K/AKT/mTOR signaling pathway via PTEN enhancement.", "Pagination": {"StartPage": "82851", "EndPage": "82863", "MedlinePgn": "82851-82863"}, "Abstract": {"AbstractText": ["Marsdenia tenacissimae extraction (MTE) as a traditional Chinese herb has long been used to treat some diseases such as tumors in China. However, the potential effectiveness of MTE in leukemia has not yet been fully understood, and the related molecular mechanism is still unknown. In the present study, we aimed to evaluate the effects of MTE on the proliferation and apoptosis of Jurkat cells (T-ALL lines) and lymphocytes from T-ALL (T-cell acute lymphoblastic leukemia) patients. Firstly, CCK8 assays and flow cytometry assays revealed that MTE dose-dependently reduced the proliferation of Jurkat cells by arresting cell cycle at S phase. Secondly, Annexin V-FITC/PI-stained flow cytometry and TUNEL staining assays showed that MTE promoted the apoptosis of Jurkat cells. Mechanistically, MTE enhanced PTEN (phosphatases and tensin homolog) level and inactivated PI3K/AKT/mTOR signaling pathway in Jurkat cells, which mediated the inhibition of cell proliferation by MTE and MTE-induced apoptosis. Finally, MTE significantly inhibited the proliferation and promoted the apoptosis of lymphocytes from T-ALL patients, compared with lymphocytes from healthy peoples. Taken together, these results reveal an unrecognized function of MTE in inhibiting the proliferation and inducing the apoptosis of T-ALL cells, and identify a pathway of PTEN/PI3K/AKT/mTOR for the effects of MTE on leukemia therapy."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China."}, {"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Wang", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Chen", "ForeName": "Bingyu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Wang", "ForeName": "Zhen", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China."}], "LastName": "Zhang", "ForeName": "Wei", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Hao", "ForeName": "Ke", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China."}], "LastName": "Chen", "ForeName": "Yu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Li", "ForeName": "Kaiqiang", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China."}], "LastName": "Wang", "ForeName": "Tongtong", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Blood Transfusion, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, 310014, China."}], "LastName": "Xie", "ForeName": "Yiwei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China."}, {"Identifier": [], "Affiliation": "Institute of Neuroscience and Hypoxia Medicine, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China."}], "LastName": "Huang", "ForeName": "Zhihui", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory of Laboratory Medicine, Ministry of Education, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China."}, {"Identifier": [], "Affiliation": "Clinical Research Institute, Zhejiang Provincial People's Hospital, Hangzhou, 310014, China."}], "LastName": "Tong", "ForeName": "Xiangmin", "Initials": "X"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Oncotarget", "NlmUniqueID": "101532965", "ISSNLinking": "1949-2553"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "EC 2.7.1.1", "NameOfSubstance": "MTOR protein, human"}, {"RegistryNumber": "EC 2.7.1.137", "NameOfSubstance": "Phosphatidylinositol 3-Kinase"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "TOR Serine-Threonine Kinases"}, {"RegistryNumber": "EC 3.1.3.67", "NameOfSubstance": "PTEN Phosphohydrolase"}, {"RegistryNumber": "EC 3.1.3.67", "NameOfSubstance": "PTEN protein, human"}], "MeshHeadingList": [{"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": [], "DescriptorName": "Dose-Response Relationship, Drug"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Jurkat Cells"}, {"QualifierName": ["chemistry"], "DescriptorName": "Marsdenia"}, {"QualifierName": ["metabolism"], "DescriptorName": "PTEN Phosphohydrolase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphatidylinositol 3-Kinase"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["drug therapy", "enzymology", "genetics", "pathology"], "DescriptorName": "Precursor T-Cell Lymphoblastic Leukemia-Lymphoma"}, {"QualifierName": ["metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["drug effects"], "DescriptorName": "S Phase Cell Cycle Checkpoints"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["metabolism"], "DescriptorName": "TOR Serine-Threonine Kinases"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Tumor Cells, Cultured"}], "CoiStatement": "<b>CONFLICTS OF INTEREST</b>. The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Belmonte M, Hoofd C, Weng AP, Giambra V. Targeting leukemia stem cells: which pathways drive self-renewal activity in T-cell acute lymphoblastic leukemia? Curr Oncol. 2016;23:34\u201341.", "ArticleIdList": ["PMC4754058", "26966402"]}, {"Citation": "Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest. 2012;122:3398\u20133406.", "ArticleIdList": ["PMC3461904", "23023710"]}, {"Citation": "Coustan-Smith E, Song G, Clark C, Key L, Liu P, Mehrpooya M, Stow P, Su X, Shurtleff S, Pui CH, Downing JR, Campana D. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood. 2011;117:6267\u20136276.", "ArticleIdList": ["PMC3122946", "21487112"]}, {"Citation": "Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008;371:1030\u20131043.", "ArticleIdList": ["18358930"]}, {"Citation": "Zhu RJ, Shen XL, Dai LL, Ai XY, Tian RH, Tang R, Hu YJ. Total aglycones from Marsdenia tenacissima increases antitumor efficacy of paclitaxel in nude mice. Molecules. 2014;19:13965\u201313975.", "ArticleIdList": ["PMC6271049", "25197933"]}, {"Citation": "Ye B, Li J, Li Z, Yang J, Niu T, Wang S. Anti-tumor activity and relative mechanism of ethanolic extract of Marsdenia tenacissima (Asclepiadaceae) against human hematologic neoplasm in vitro and in vivo. J Ethnopharmacol. 2014;153:258\u2013267.", "ArticleIdList": ["24583069"]}, {"Citation": "Fan W, Sun L, Zhou JQ, Zhang C, Qin S, Tang Y, Liu Y, Lin SS, Yuan ST. Marsdenia tenacissima extract induces G0/G1 cell cycle arrest in human esophageal carcinoma cells by inhibiting mitogen-activated protein kinase (MAPK) signaling pathway. Chin J Nat Med. 2015;13:428\u2013437.", "ArticleIdList": ["26073339"]}, {"Citation": "Huang Z, Wang Y, Chen J, Wang R, Chen Q. Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients. J Tradit Chin Med. 2013;33:34\u201338.", "ArticleIdList": ["23596809"]}, {"Citation": "Han SY, Zhao W, Sun H, Zhou N, Zhou F, An G, Li PP. Marsdenia tenacissima extract enhances gefitinib efficacy in non-small cell lung cancer xenografts. Phytomedicine. 2015;22:560\u2013567.", "ArticleIdList": ["25981922"]}, {"Citation": "Xue HL, Huang XD, He D, Lin SJ, Wang S, Niu T. [Effects of Marsdenia tenacissima extract on proliferation and apoptosis of hematologic neoplasm cell line cells]. [Article in Chinese] Sichuan Da Xue Xue Bao Yi Xue Ban. 2012;43:174\u2013179.", "ArticleIdList": ["22650025"]}, {"Citation": "Li D, Li C, Song Y, Zhou M, Sun X, Zhu X, Zhang F, Zhou C, Huan Y, Xia S, Zhuo X, Dong P, Sui X, Liao H, Yang ZF. Marsdenia tenacssima extract and its functional components inhibits proliferation and induces apoptosis of human Burkitt leukemia/lymphoma cells in vitro and in vivo. Leuk Lymphoma. 2015:1\u201310.", "ArticleIdList": ["25942381"]}, {"Citation": "Hopkins BD, Hodakoski C, Barrows D, Mense SM, Parsons RE. PTEN function: the long and the short of it. Trends Biochem Sci. 2014;39:183\u2013190.", "ArticleIdList": ["PMC4043120", "24656806"]}, {"Citation": "Lim HJ, Crowe P, Yang JL. Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer. J Cancer Res Clin Oncol. 2015;141:671\u2013689.", "ArticleIdList": ["25146530"]}, {"Citation": "Han SY, Ding HR, Zhao W, Teng F, Li PP. Enhancement of gefitinib-induced growth inhibition by Marsdenia tenacissima extract in non-small cell lung cancer cells expressing wild or mutant EGFR. BMC Complement Altern Med. 2014;14:165.", "ArticleIdList": ["PMC4040364", "24884778"]}, {"Citation": "Huang T, Gong WH, Zou CP, Li XC, Jiang GJ, Li XH, Qian H. Marsdenia tenacissima extract sensitizes MG63 cells to doxorubicin-induced apoptosis. Genet Mol Res. 2014;13:354\u2013362.", "ArticleIdList": ["24535862"]}, {"Citation": "Bhola PD, Letai A. Mitochondria-Judges and Executioners of Cell Death Sentences. Mol Cell. 2016;61:695\u2013704.", "ArticleIdList": ["PMC4806554", "26942674"]}, {"Citation": "Liu W, Zhou Y, Reske SN, Shen C. PTEN mutation: many birds with one stone in tumorigenesis. Anticancer Res. 2008;28:3613\u20133619.", "ArticleIdList": ["19189642"]}, {"Citation": "Shi Y, Wang J, Chandarlapaty S, Cross J, Thompson C, Rosen N, Jiang X. PTEN is a protein tyrosine phosphatase for IRS1. Nat Struct Mol Biol. 2014;21:522\u2013527.", "ArticleIdList": ["PMC4167033", "24814346"]}, {"Citation": "Fragoso R, Barata JT. PTEN, leukemia stem cells. Adv Biol Regul. 2014;56:22\u201329.", "ArticleIdList": ["24961634"]}, {"Citation": "Ferri C, Bianchini M, Bengio R, Larripa I. Expression of LYN and PTEN genes in chronic myeloid leukemia and their importance in therapeutic strategy. Blood Cells Mol Dis. 2014;52:121\u2013125.", "ArticleIdList": ["24091144"]}, {"Citation": "Herranz D, Ambesi-Impiombato A, Sudderth J, Sanchez-Martin M, Belver L, Tosello V, Xu L, Wendorff AA, Castillo M, Haydu JE, Marquez J, Mates JM, Kung AL, Rayport S, Cordon-Cardo C, DeBerardinis RJ, et al. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nat Med. 2015;21:1182\u20131189.", "ArticleIdList": ["PMC4598309", "26390244"]}, {"Citation": "Lonetti A, Cappellini A, Sparta AM, Chiarini F, Buontempo F, Evangelisti C, Orsini E, McCubrey JA, Martelli AM. PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. Oncotarget. 2015;6:10399\u201310414. doi: 10.18632/oncotarget.3295.", "ArticleIdList": ["10.18632/oncotarget.3295", "PMC4496363", "25871383"]}, {"Citation": "Lynch JT, McEwen R, Crafter C, McDermott U, Garnett MJ, Barry ST, Davies BR. Identification of differential PI3K pathway target dependencies in T-cell acute lymphoblastic leukemia through a large cancer cell panel screen. Oncotarget. 2016;7:22128\u201322139. doi: 10.18632/oncotarget.8031.", "ArticleIdList": ["10.18632/oncotarget.8031", "PMC5008349", "26989080"]}, {"Citation": "Ciofani M, Zuniga-Pflucker JC. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol. 2005;6:881\u2013888.", "ArticleIdList": ["16056227"]}, {"Citation": "Palomero T, Sulis ML, Cortina M, Real PJ, Barnes K, Ciofani M, Caparros E, Buteau J, Brown K, Perkins SL, Bhagat G, Agarwal AM, Basso G, Castillo M, Nagase S, Cordon-Cardo C, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13:1203\u20131210.", "ArticleIdList": ["PMC2600418", "17873882"]}, {"Citation": "Zuurbier L, Petricoin EF, 3rd, Vuerhard MJ, Calvert V, Kooi C, Buijs-Gladdines JG, Smits WK, Sonneveld E, Veerman AJ, Kamps WA, Horstmann M, Pieters R, Meijerink JP. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia. Haematologica. 2012;97:1405\u20131413.", "ArticleIdList": ["PMC3436243", "22491738"]}, {"Citation": "Bandapalli OR, Zimmermann M, Kox C, Stanulla M, Schrappe M, Ludwig WD, Koehler R, Muckenthaler MU, Kulozik AE. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia. Haematologica. 2013;98:928\u2013936.", "ArticleIdList": ["PMC3669450", "23349303"]}, {"Citation": "Trinquand A, Tanguy-Schmidt A, Ben Abdelali R, Lambert J, Beldjord K, Lengline E, De Gunzburg N, Payet-Bornet D, Lhermitte L, Mossafa H, Lheritier V, Bond J, Huguet F, Buzyn A, Leguay T, Cahn JY, et al. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study. J Clin Oncol. 2013;31:4333\u20134342.", "ArticleIdList": ["24166518"]}, {"Citation": "Gutierrez A, Sanda T, Grebliunaite R, Carracedo A, Salmena L, Ahn Y, Dahlberg S, Neuberg D, Moreau LA, Winter SS, Larson R, Zhang J, Protopopov A, Chin L, Pandolfi PP, Silverman LB, et al. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia. Blood. 2009;114:647\u2013650.", "ArticleIdList": ["PMC2713461", "19458356"]}, {"Citation": "Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A, Werft W, Breit S, Liu S, Engel F, Wittmann A, Zimmermann M, Stanulla M, Schrappe M, Ludwig WD, Bartram CR, et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16. 1 as a genomic marker for unfavorable early treatment response. Blood. 2009;114:1053\u20131062.", "ArticleIdList": ["19406988"]}, {"Citation": "Jotta PY, Ganazza MA, Silva A, Viana MB, da Silva MJ, Zambaldi LJ, Barata JT, Brandalise SR, Yunes JA. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia. Leukemia. 2010;24:239\u2013242.", "ArticleIdList": ["19829307"]}, {"Citation": "Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481:157\u2013163.", "ArticleIdList": ["PMC3267575", "22237106"]}, {"Citation": "Han SY, Zhao HY, Zhou N, Zhou F, Li PP. Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes. J Ethnopharmacol. 2014;151:210\u2013217.", "ArticleIdList": ["24157377"]}, {"Citation": "Zhang M, Pan Y, Dorfman RG, Chen Z, Liu F, Zhou Q, Huang S, Zhang J, Yang D, Liu J. AR-42 induces apoptosis in human hepatocellular carcinoma cells via HDAC5 inhibition. Oncotarget. 2016;7:22285\u201322294. doi: 10.18632/oncotarget.8077.", "ArticleIdList": ["10.18632/oncotarget.8077", "PMC5007137", "26993777"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "6", "Day": "29"}, {"Year": "2016", "Month": "10", "Day": "3"}, {"Year": "2016", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "10", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27756877", "PMC5347737", "10.18632/oncotarget.12654", "12654"]}}], "PubmedBookArticle": []}